Human immunodeficiency virus in women: Mucocutaneous manifestations

Clinics in Dermatology

Volumn 15, Issue 1, 1997, Pages 93-111

  Wright, Sylvia W ^a   Johnson, Richard A ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; GAMMA INTERFERON; PERMETHRIN; VINBLASTINE; VINCRISTINE; ZIDOVUDINE;

ARTICLE; CANDIDIASIS; CLINICAL FEATURE; CRYOTHERAPY; CYTOMEGALOVIRUS INFECTION; DERMADROME; EPSTEIN BARR VIRUS; FEMALE; HERPES ZOSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; IMMUNOTHERAPY; KAPOSI SARCOMA; LASER SURGERY; LEUKOPLAKIA; MOLLUSCUM CONTAGIOSUM; MYCOBACTERIOSIS; PRIORITY JOURNAL; PROTOZOAL INFECTION; SCABIES; SKIN INFECTION; WART VIRUS;

EID: 0031081768     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(96)00113-7     Document Type: Article

References (201)

1. 1. The Global AIDS Policy Coalition. Status and trends of the HIV/AIDS. Status and trends of the HIV/AIDS pandemic as of January 1996. Cambridge: Harvard School of Public Health.
2. 2. Keenlyside RA, Johnson AM, Mabey DCW. The epidemiology by HIV-1 infection and AIDS in women. AIDS 1993;7 (suppl 1):583-90.
3. 3. Vincenzi I. European Study Group on Heterosexual Transmission of HIV: A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. N Engl J Med 1995;331:341-6.
4. 4. European Study Group on Heterosexual Transmission of HIV. Comparison of female to male and male to female transmission in 563 stable couples. Br Med J 1992;304: 807-13.
5. 5. Rehmet S, Staszewski S, Muller R, et al. Transmission rates and co-factors of heterosexual HIV infection. Eighth International Conference on AIDS, Amsterdam, 1992;8:C272.
6. 6. American Association for World Health. Shared rights, shared responsibilities. World AIDS Day, December 1995.
7. 7. Centers for Disease Control and Prevention. Update: AIDS among women - United States, 1994. MMWR 1994;44(5):81-4.
8. 8. Centers for Disease Control and Prevention. HIV/AIDS surveillance report. Mid-year edition 1995;7:2-34.
9. 9. Carpenter CCJ, Mayer KH, Stein MD, et al. Human immunodeficiency virus infection in North American Women: experience with 200 cases and a review of the literature. Medicine 1991;70:307-25.
10. 10. Cozzi Lepri A, Pessotti P, Dorrucci M, et al. HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from serconversion. Br Med J 1994;1537-42.
11. 11. Brettle RP, Lien CLS. The natural history of HIV infection in women: A six year longitudinal, observational study. Proc 9th Int Conf AIDS, Berlin, 1993; abstract no. 801-0871.
12. 12. Lassoued K, Clauvel J-P, Fegueux S, et al. AIDS-associated Kaposi's Sarcoma in female patients. AIDS 1991;5:877-80.
13. 13. Cooley TP, Khuri F, O'Keane JC. Kaposi's sarcoma in women with AIDS. Proc 9th Int Con AIDS, Berlin 1993;9(1)398.
14. 14. Beral V, Petermen TA, Berkelman RL, et al. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection. Lancet 1990;335:123-8.
15. 15. Coodley GO, Coodley MK, Thompson AF. Clinical aspects of HIV infection in women. J Gen Int Med 1995;10: 99-110.
16. 16. Johnstone FD, Willocks L, Brettle RP: Survival time after AIDS in pregnancy. Br J Obstet Gyn 1982;99:633-6.
17. 17. Alger LS, Parley JJ, Robinson BA, et al. Interactions of human immunodeficiency virus infection and pregnancy. Obstet Gynecol 1993;82:787-96.
18. 18. Duff D. Human immunodeficiency virus infection in pregnancy. Semin Perinatology 1993;17:379-83.
19. 19. Deschamps M, Pape JW, Devarieux, et al. A prospective study of HIV-seropositive asymptomatic women of childbearing age in a developing country. J Acq Imm Def Synd 1993;6:446-51.
20. 20. Berrebi A, Kobuch WE, Puel J. Influence of pregnancy on human immunodeficiency virus disease. Eur J Obstet Gynecol Reprod Biol 1990;37:211-7.
21. 21. Brettle RP, Raab GM, Ross A, et al. HIV infection in women: immunologic markers and the influence of pregnancy. AIDS 1995;9:1177-84.
22. 22. Centers for Disease Control and Prevention. Zidovudine for the prevention of HIV transmission from mother to infant. MMWR 1994;43:285-7.
23. 23. Chang Y, Cesarman E, Pess MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-9.
24. 24. Moore PS, Change Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. N Engl J Med 1995;332:1181-5.
25. 25. Berel V, Peterman TA, Berkelman RL, et al. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection. Lancet 1990;335:123-8.
26. 26. Serraino D, Franceschi S, DalMaso L, et al. HIV transmission and Kaposi's sarcoma among European women. AIDS 1995;9:971-4.
27. 27. Tappero JW, Conant MA, Wolfe SF, et al. Kaposi's sarcoma: Epidemiology, pathogenesis, histology, clinical presentation, staging criteria and therapy. J Am Acad Dermatol 1993;28:371-95.
28. 28. Janier M, More IP, Civatte J. The Koebner Phenomenon in AIDS-related Kaposi's sarcoma. J Am Acad Dermatol 1990;22:125-6.
29. 29. Ficarra G, Berson AM, Silvermans, et al. Kaposi's Sarcoma of the oral cavity: A study of the pathogenesis, epidemiology, clinical aspects and treatment. Oral Surg Oral Med Oral Pathol 1988;66:543-50.
30. 30. McKenzie R, Travis WD, Dolan SA, et al. The causes of death in patients with human immunodeficiency virus infection: A clinical and pathologic study with emphasis on the role of pulmonary disease. Medicine 1991;70:326-43.
31. 31. Chachova A, Krigel R, Lafleur F, et al. Prognostic factors and staging classifications of patients with epidemic Kaposi's sarcoma. J Clin Oncol 1989;7:774-80.
32. 32. Tappero JW, Berger TG, Lawrence KD, et al. Cryotherapy for cutaneous Kaposi's sarcoma (KS) associated with acquired immune deficiency syndrome (AIDS): A phase II trial. J AIDS 1991;4:839-46.
33. 33. Boudreaux AA, Smith LL, Cosby CD, et al. Intralesional vinblastine for cutaneous Kaposi's Sarcoma associated with acquired immunodeficiency syndrome: A clinical trial to evaluate efficiency and discomfort associated with injection. J Am Acad Dermatol 1993;28:61-5.
34. 34. Conant MA, Galzagorry G, Ilkman M. Intralesional vinblastine (Velban) treatment of lesions of Kaposi's Sarcoma. Int Conf AIDS 1989;5:335.
35. 35. Sulis E, Floris C, Sulis ML, et al. Interferon administered intralesionally in skin and oral cavity in heterosexual drug-addicted patients with AIDS-related Kaposi's sarcoma. Eur J Cancer Clin Oncol 1989;25:750-61.
36. 36. Berson AM, Quivey JM, Harris JW, et al. Radiation therapy for AIDS-related Kaposi's Sarcoma. Int J Rad Oncol Biol Phys 1990;19:569-75.
37. 37. Cooper JS, Steinfeld AD, Lerch I. Intentions and outcomes in radiotherapeutic management of epidemic Kaposi's Sarcoma. Int J Rad Oncol Biol Phys 1991;20:419:22.
38. 38. Tappero JW, Berger TG. Pulsed-dye laser therapy for cutaneous Kaposi's Sarcoma associated with acquired immunodeficiency syndrome. J Am Acad Dermatol 1991; 27:526-30.
39. 39. Krown SE, Mysekowski PL, Paredes J. Kaposi's sarcoma: Medical management of AIDS patients. Med Clin North Am 1992;76:235-57.
40. 40. Imam N, Carpenter CCJ, Mayer KH, et al. Hierarchical pattern of mucosal Candida infections in HIV-seropositive women. Am J Med 1990;89:142-146.
41. 41. Saville MW, Lietzau J, Pluda JM, et al. Treatment of Kaposi's Sarcoma with Paelitaxel. Lancet 1995;346:26-28.
42. 42. Rhoads JL, Wright DC, Redfield RR. Chronic vaginal candidosis in women with human immunodeficiency virus infection. JAMA 1987;357:3105-7.
43. 43. Spinillo A, Michelone G, Cavanna C. Clinical and microbiological characteristics of symptomatic vulvovaginal candidiasis in HIV seropositive women. Genitourin Med 1994;70:268-72.
44. 44. Johnson RA, Dover JS. Cutaneous manifestations of human immunodeficiency virus disease. In Fitzpatrick TB, Eison AZ, Wolff K, et al, editors. Dermatology in general medicine. New York: McGraw-Hill, 1993;215:2654.
45. 45. Sha BE, Benson CA, Pottage JC, et al. HIV infection in women: An observational study of clinical characteristics, disease progression and survival for a cohort of women in Chicago. J AIDS 1995;8:486-95.
46. 46. Raviglione MC, Mariuz P, Pablos-Mendez A, et al. High Staphiococcal aurcus nasal carriage in patients with acquired immunodeficiency syndrome or AIDS-related complex. Am J Infect Control 1990;18:64-9.
47. 47. Battan R, Raviglione MC, Wallace J, et al. S. aureus nasal carriage among homosexual men with and without HIV infection. Am J Infect Control 1991;19:98-100.
48. 48. Donovan B, Rohrsheim R, Bassett I, et al. Bullous impetigo in homosexual men - a risk marker for HIV-infection? Genitourin Med 1992;68:159-61.
49. 49. Patterson JW, Kitces EN, Neafie RC. Cutaneous botryomycosis in a patient with acquired immunodeficiency syndrome. J Am Acad Dermatol 1987;16:238-42.
50. 50. Becker BA, Frieden H, Odom RB, et al. Atypical plaque-like staphlococcal folliculitis in human immunodeficiency virus-infected persons. J Am Acad Derm 1989;21: 1024-6.
51. 51. Duvic M. Stapholococcal infections and the pruritus of AIDS related complex. Arch Dermatol 1987;125:1599-1600.
52. 52. Boudreau S, Hines HC, Hood AF. Dermal abscesses with Staphylococcus aureus, cytomegalovirus and acid-fast bacilli in a patient with acquired immunodeficiency syndrome (AIDS). J Cutan Pathol 1988;15:53-7.
53. 53. Richard M, Mathieu-Serra A. Staphylococcal scalded skin syndrome in a homosexual adult. J Am Acad Dermatol 1986;15:385-9.
54. 54. Kline MW, Dunkle LM. Toxic shock syndrome and the acquired immunodeficiency syndrome. Pediatr Infect Dis 1988;10:736-8.
55. 55. DiSilverio A, Brazelli V, Brandozzi G, et al. Prevalence of dermatophytes and yeasts in HIV patients: A study of former drug addicts. Mycopathologica 1991;114:103-7.
56. 56. Dompmartin D, Dompmartin A, Deluol AM, et al. Onychomycosis and AIDS: Clinical and laboratory findings in 62 patients. Int J Dermatol 1990;29:337-9.
57. 57. Mathes BM, Douglass MC. Seborrheic dermatitis in patients with acquired immunodeficiency syndrome. J Am Acad Dermatol 1985;13:947-51.
58. 58. Heng MC, Henderson LL, Baker DC, et al. Correlation of Pityrosporum ovale density with clinical severity of seborrheic dermatitis as assessed by a simplified technique. J Am Acad Dermatol 1990;23:83-6.
59. 59. Wilker JR, Niboer C, Willemze R. Quantitative skin cultures of Pityrosporum yeasts in patients seropositive for the human immunodeficiency virus with and without seborrheic dermatitis. J Am Acad Dermatol 1992;27:37-9.
60. 60. Cohen PR, Bank DE, Silver DN, et al. Cutaneous lesions of disseminated histoplasmosis in human immunodeficiency virus-infected patients. J Am Acad Dermatol 1990; 23:422-8.
61. 61. Bonner JR, Alexander WJ, Dismukes WE, et al. Disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. Arch Int Med 1984;144:2178-81.
62. 62. Hazelhurst JA, Vismer HF, Histoplasmosis presenting with unusual skin lesions in acquired immunodeficiency syndrome (AIDS). Br J Dermatol 1985;113:345-8.
63. 63. Ibanez HE, Ibanez MA. Case report: a new presentation of disseminated histoplasmosis in a homosexual male with AIDS. Am J Med Sci 1989;298:407-9.
64. 64. Greenberg RG, Berger TG. Progressive disseminated histoplasmosis in acquired immunodeficiency syndrome: Presentation as a steroid-responsive dermatosis. Cutis 1989;43:535-8.
65. 65. Cohen PR, Held JL, Grossman ME, et al. Disseminated histoplasmosis presenting as an ulcerated verrucous plaque in an HIV-infected man. Int J Dermatol 1991;30: 104-8.
66. 66. Eisig S, Bouguslaw B, Cooperband B, et al. Oral manifestations of disseminated histoplasmosis in acquired immunodeficiency syndrome. J Oral Maxillofac Surg 1991;49:310-3.
67. 67. Johnson PC, Khardori N, Najjar AF, et al. Progressive disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. Am J Med 1988;85:152-8.
68. 68. Eng RH, Bishburg E, Smith SM. Cryptococcal infections with patients with acquired immunodeficiency syndrome. Am J Med 1986;81:19-3.
69. 69. Powderly WG, Saag MS, Cloud GA, et al. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 1992;326: 793-8.
70. 70. Shahab ST, Habts-Gabr E, Fedorko D. Significance of cryptococcal antigentiters in patients with AIDS. South Med J 1991;84:1407-8.
71. 71. Durden FM, Elewski B. Cutaneous involvement of Cryptococcus neoformans in AIDS. JAAD 1994;30:844-8.
72. 72. Iacobellis FW, Jacobs ML, Cohen RP, Primary cutaneous cryptococcosis. Arch Dermatol 1976;112:1734-40.
73. 73. Hernandez AD. Cutaneous crytococcosis. Dermatol Clin 1989;7:269-74.
74. 74. Denning DW, Tucker RM, Hanson LH, et al. Itraconazole therapy for cryptococcal meningitis and cryptococcosis. Arch Int Med 1989;149:2301-8.
75. 75. Blauvelt A, Kerdel FA. Cutaneous cryptococcosis mimicking Kaposi's sarcoma as the initial manifestation of disseminated disease. Int J Dermatol 1992;31:279-80.
76. 76. Sarosi GA, Silberfarb PM, Tosh FE. Cutaneous cryptococcosis, A sentinel of disseminated disease. Arch Dermatol 1971;104:1-3.
77. 77. Manrique P, Mayo J, Alverez JA, et al. Polymorphous cutaneous cryptococcosis: nodular herpes-like, and molluscum contagiosum-like lesions in a patient with acquired immunodeficiency syndrome. J Am Acad Dermatol 1992;26:122-4.
78. 78. Concus AM, Helfand RF, Imber MJ, et al. Cutaneous cryptococcosis mimicking molluscum contagiosum in a patient with AIDS. J Infect Dis 1988;158:897-8.
79. 79. Ricchi E, Manfredi R, Scarvani P, et al. Cutaneous cryptococcosis and AIDS. J Am Acad Dermatol 1991;25:335-6.
80. 80. Borton LK, Wintroub BV. Disseminated cryptococcosis presenting as herpetiform lesions in a homosexual man with acquired immunodeficiency syndrome. J Am Acad Dermatol 1984;10:387-90.
81. 82. Schubach CW, Wheeler E, Briggaman RA, et al. Cutaneous manifestations of disseminated cryptococcosis. Arch Dermatol 1976;112:1734-40.
82. 83. Gauder JP. Cryptococcal cellulitis. JAMA 1977;237:672-3.
83. 84. Kruyswijk MR, Keuning JJ. Cutaneous cryptococcosis in a patient receiving immunosuppressive drugs for systemic lupus erythematosus. Dermatologica 1980;161: 280-4.
84. 85. Green MH, Macher AM, Hernandez AD, et al. Disseminated cryptococcosis presenting as palpable purpura. Arch Int Med 1978;138:1412-3.
85. 86. Lui H, McLeod A, Wood WS. An ulcerated plaque in a gay man. Arch Dermatol 1993;129:501-2.
86. 87. Massa MC, Doyle JA. Cutaneous cryptococcosis simulating pyoderma gangrenosum. J Am Acad Dermatol 1981; 5:32-6.
87. 88. Saag MS, Powderly WG, Cloud GA, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1992;326:83-9.
88. 89. Powderly WG, Saag MS, Cloud Gas, et al. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with acquired immunodeficiency syndrome. N Engl J Med 1992;326:793-8.
89. 90. Bronnimann DA, Adam RD, Galgian JN, et al. Coccidioidomycosis in the acquired immunodeficiency syndrome. Ann Intern Med 1987;106:372-9.
90. 91. Hobbs ER. Coccidioidomycosis. Dermatol Clin 1989;7: 227-39.
91. 92. Prichard JG, Sorotzkin RA, James RE III, et al. Cutaneous manifestations of disseminated coccidioidomycosis in the acquired immunodeficiency syndrome. Cutis 1987; 39:203-5.
92. 93. Harvey WC, Greendyke WH. Skin lesions in acute coccidioidomycosis. Am Fam Physician 1970;2:81-5.
93. 94. Drutz DJ, Catanzaro A. State of the art: Coccidioidomycosis. Am Rev Resp Dis 1978;117:559-85.
94. 95. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987;36:3S-15S.
95. 96. Toback AC, Grossman ME. Chronic intraoral herpes simplex infection in renal transplant recipients. Transplant Proc 1986;18:966-9.
96. 97. Grossman ME, Stevens AW, Cohen PR. Herpetic geometric glossitis. N Engl J Med 1993;329:1859-60.
97. 98. Sacks SL, Wanklin RJ, Reece DE, et al. Progressive esophogitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity? Ann Intern Med 1989;111:893-9.
98. 99. Marks GL, Nolan PE, Erlich KS, et al. Mucocutaneous dissemination of acyclovir-resistant herpes simplex virus infection in a patient with AIDS. Rev Infect Dis 1989;11: 474-6.
99. 100. Zimmerli W, Bianchi L, Gudat F, et al. Disseminated herpes simplex type 2 and systemic Candida infection in a patient with previous asymptomatic human immunodeficiency virus infection. J Infect Dis 1988;157:597-8.
100. 101. Hook EW III, Cannon RO, Nahmias AJ, et al. Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J Infect Dis 1992;265:251-5.
101. 102. Holmberg SD, Stewart JA, Gerber AR, et al. Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA 1988;259:1048-50.
102. 103. Norris SA, Kessler HA, Fife KH. Severe progressive herpetic whitlow caused by an acyclovir-resistant virus in a patient with AIDS. J Infect Dis 1988;157:209-10.
103. 104. Baden LA, Bigby M, Kwan T. Off-centerfold: Persistent necrotic drugs in a patient with acquired immunodeficiency syndrome. Arch Dermatol 1991;127:113-6.
104. 105. Hardy WD. Foscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: Preliminary results of a controlled randomized regimen-comparative trial. Am J Med 1992;92:30S-5S.
105. 106. Safrin S, Crumpacker C, Chatis P, et al. A controlled trial comparing foscarnet with vidaribine for acyclovirresistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. N Engl J Med 1991;325: 551-5.
106. 107. Engel JP, Englund JA, Fletcher CV, et al. Treatment of resistant herpes simplex virus with continuous-infusion acyclovir. JAMA 1990;263:1662-4.
107. 108. Perronne C, Lazanas M, Leport C, et al. Varicella in patients infected with the human immunodeficiency virus. Arch Dermatol 1990;126:1033-6.
108. 109. Jura E, Chadwick EG, Josephs SH, et al. Varicella-zoster infections in children infected with human immunodeficiency virus. Ped Infect Dis J 1989;8:586-90.
109. 110. Pahwa S, Biron K, Lim W, et al. Continuous varicellazoster infections associated with resistance in a child with AIDS. JAMA 1988;260:2879-82.
110. 111. Cohen PR, Grossman ME. Clinical features of human immunodeficiency virus-associated disseminated herpes zoster virus infection - a review of the literature. Clin Exp Dermatol 1989;14:273-6.
111. 112. LeVoit PE, Limova M, Yens TS, et al. Chronic verrucous varicella-zoster virus infection in patients with acquired immunodeficiency syndrome (AIDS). Am J Dermatopath 1991;14:1-7.
112. 113. Leibovitz E, Kaul A, Rigaud M, et al. Chronic varicella zoster in a child infected with human immunodeficiency virus: Case report and review of the literature. Cutis 1992;49:27-31.
113. 114. Disler RS, Dover JS. Chronic localized herpes zoster in the acquired immunodeficiency syndrome. Arch Dermatol 1990;126:1105-6.
114. 115. Patterson LE, Butler KM, Edwards MS, et al. Clinical herpes zoster shortly following primary varicella in two HIV-infected children. Clin Pediatr (Phila) 1989;28:354.
115. 116. Safrin S, Berger TG, Gilson I, et al. Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infection. Ann Intern Med 1991;115:19-21.
116. 117. Jacobson MA, Berger TG, Fikrig S, et al. Acyclovir-resistant varicella-zoster virus infection after chronic oral acyclovir therapy in patients with acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1990;112: 187-91.
117. 118. Feingold AR, Vermund SH, Burk RD, et al. Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. J AIDS 1990;3:896-903.
118. 119. Schafer A, Friedmann W, Mielke M, et al. The increased frequency of cervical dysplasia - neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression. Am J Obstet Gynecol 1991;164:593-9.
119. 120. Vermund SH, Kelley KK, Klein RS, et al. High risk of human papilloma virus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol 1991;165:392-400.
120. 121. Centers for Disease Control and Prevention. 1991 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41:1-19.
121. 122. Berger TG, Sawchuk WS, Leonardi C, et al. Epidermodysplasia verruciformis-associated Papillomavirus infection complicating human immunodeficiency virus disease. Br J Dermatol 1991;124:79-83.
122. 123. Prose NS, von Knebel-Doeberitz C, Miller S, et al. Widespread flat warts associated with human papillomavirus 5: A cutaneous manifestation of human immunodeficiency virus infection. J Am Acad Dermatol 1990;23:978-81.
123. 124. Goette DK. Topical chemotherapy with 5-flourouracil. J Am Acad Dermatol 1981;4:633-9.
124. 125. Shumer SM, O'Keefe EJ. Bleomycin in the treatment of recalcitrant warts. J Am Acad Dermatol 1983,9:91-6.
125. 126. Sawchuk WS, Weber PJ, Lowy DR, et al. Infectious papillomavirus in the vapor of warts treated with carbon dioxide laser or electrocoagulation. Detection and protection. J Am Acad Dermatol 1989;21:41-9.
126. 127. Douglas JM, Rogers M, Judson FM. The effect of asymptomatic infection with HTLV-III on the response of anogenital warts to intralesional treatment with recombinant alpha interferon. J Infect Dis 1986;154:331-4.
127. 128. Bournerias I, Boisnic S, Patey O, et al. Unusual cutaneous cytomegalovirus involvement in patients with acquired immunodeficiency syndrome. Arch Dermatol 1989;125: 1243-6.
128. 129. Bhawan J, Gelliss S, Ucci A, et al. Vesicobullous lesions caused by cytomegalovirus infection in an immunocompromised adult. J Am Acad Dermatol 1984;11:743-7.
129. 130. Lee JY. Cytomegalovirus infection involving the skin in immunocompromised hosts. A clinicopathologic study. Am J Clin Pathol 1989;92:96-100.
130. 131. Curtis JL, Egbert BM. Cutaneous cytomegalovirus vasculitis: an unusual presentation of a common opportunistic pathogen. Hum Pathol 1982;12:1138-41.
131. 132. Smith KJ, Skelton HG, Yeager J, et al. Cutaneous thrombosis in human immunodeficiency virus type-1 positive patients and cytomegalovirus viremia. Arch Dermatol 1995;131:357-8.
132. 133. Horn TD, Hood AF. Cytomegalovirus is predictably present in perineal ulcers from immunosuppressed patients. Arch Dermatol 1990-126:642-4.
133. 134. Greenspan JS, Greenspan D, Lennette ET, et al. Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. N Engl J Med 1985;313:1564-71.
134. 135. Resnick L, Herbst JS, Raab-Traub N. Oral hairy leuko" plakia. J Am Acad Dermatol 1990;22:1278-82.
135. 136. Shiboski CH, Hilton JF, Greenspan D, et al. HIV related oral manifestations in two cohorts of women in San Fransciso. J AIDS 1994;7:964-71.
136. 137. Sanchez M, Spielman T, Epstein W, et al. Treatment of oral hairy leukoplakia with podophyllin. Arch Dermatol 1992;128:1659.
137. 138. Lozada-Nur F. Podophyllin resin 25% for the treatment of oral hairy leukoplakia: An old treatment for a new lesion. J AIDS 1991;4:543-6.
138. 139. Greenspan D, DeSouza YG, Conant MA, et I. Efficacy of desiclovir in the treatment of Epstein-Barr virus infection. J AIDS 1990;3:571-8.
139. 140. Matis WL, Triana A, Shapiro R, et al. Dermatologic findings associated with human immunodeficiency virus infection virus. J Am Acad Dermatol 1987;17:746-51.
140. 141. Sarma DP, Weilbaecher TG. Molluscum contagiosum in the acquired immunodeficiency syndrome. J AM Acad Dermatol 1985;13:682-3.
141. 142. Schwartz JJ, Myskowski PL. Molluscum contagiosum in patients with human immunodeficiency virus infection. J AM Acad Dermatol 1992;27:583-8.
142. 143. Petersen CS, Gerstoft J. Molluscum contagiosum in HIV-infected patients. Dermatology 1992;184:19-21.
143. 144. Itin PH, Gilli L. Molluscum contagiosum mimicking sebaceus nevus of Jadassohn, ecthyma, and giant condylomata acuminata in HIV-infected patients. Dermatology 1994;189:396-8.
144. 145. Schwartz JJ, Myskowski PL. HIV-related molluscum contagiosum presenting as a cutaneous horn. Int J Dermatol 1992;31:142-4.
145. 146. Syed TA, Lundin S, Ahmad M. Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of molluscum contagiosum in males. A placebo-controlled, double-blind study. Dermatology 1994;189:65-8.
146. 147. Funkhouser M, Omohundro C, Rossa, et al. Management of scabies in patients with HIV disease. Arch Dermatol 1993;29:911-3.
147. 148. Arico M, Noto G, LaRocca E, et al. Localized crusted scabies in the acquired immunodeficiency syndrome. Clin Ex Dermatol 1992;17:339-41.
148. 149. Donabedian H, Khazan U. Norwegian scabies in a patient with AIDS. Clin Infect Dis 1992;14:162-4.
149. 150. Inserra DW, Bickley LK, Crusted scabies in acquired immunodeficiency syndrome. Int J Dermatol 1990;29:287-9.
150. 151. Meinking TL, Taplin D, Hermida L, et al. The treatment of scabies with ivermectin. N Engl J Med 1995;333:26-30.
151. 152. Hulbert TV, Larsen RA. Hyperkeratotic (Norwegian) scabies with gram negative bacteria as the initial presentation of AIDS. Clin Inf Dis 1992;14:1164-5.
152. 153. Glover A, Young L, Goltz AW. Norwegian scabies in acquired immunodeficiency syndrome: report of a case resulting in death from associated sepsis. J Am Acad Derm 1987;17:396-9.
153. 154. Sadick N, Kaplan MH, Pahwa SG, et al. Unusual features of scabies complicating human T-lymphotrophic virus type III infection. J Am Acad Dermatol 1986;15:482-6.
154. 155. Lupatkin H, Brau N, Flomenberg P, et al. Tuberculous abscesses in patients with AIDS. Clin Inf Dis 1992;14: 1040-4.
155. 156. Rohatgi PK, Palazzlo JV, Saini NB. Acute miliary tuberculosis of the skin in acquired immunodeficiency syndrome. J Am Acad Dermatol 1992;26:356-9.
156. 157. Stack RJ, Bickley LK, Coppel IG. Miliary tuberculosis presenting as skin lesions in a patient with acquried immunodeficiency syndrome. J Am Acad Dermatol 1990; 23:1031-5.
157. 158. Mehlmauer MA. Keratotic papules and nodules and hyperkeratosis of palms and soles in a patient with tuberculosis and AIDS-related complex. J Am Acad Dermatol 1990;23:381-5.
158. 159. Volpe F, Schwimmer A, Barr C. Oral manifestations of disseminated MAI in a patient with AIDS. Oral Surg Oral Med Oral Pathol 1985;60:567-70.
159. 160. Freed JA, Pervez NK, Chen V, et al. Cutaneous mycobacteriosis: Occurrence and significance in two patients with the acquired immunodeficiency syndrome. Arch Dermatol 1987;123:1601-3.
160. 161. Decoste SD, Dover JS. Kaposi's sarcoma and MAI with cellulitis in a patient with AIDS. J Am Acad Dermatol 1989;21:574-6.
161. 162. Piketty C, Danic DL, Weiss L, et al. Sporotrichosis-like infection caused by Mycobacterium avium in the acquired immunodeficiency syndrome. Arch Dermatol 1993;129: 1343-4.
162. 163. Pennys NS, Hicks B. Unusual cutaneous lesions associated with acquired immunodeficiency syndrome. J Am Acad Dermatol 1985;13:845-52.
163. 164. Tappero JW, Perkins BA, Wenger JD, et al. Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus. Clin Microbiol Rev 1995;8:440-50.
164. 165. Cotess SL, Noskin GA, Bacillary angiomatosis. Clinical and histologic features, diagnosis, and treatment. Arch Int Med 1994;154:524-8.
165. 166. Cockerell CJ. Bacillary angiomatosis and related diseases caused by Rochalimaea. J Am Acad Dermatol 1995;32:783-90.
166. 167. Berger TG, Koehler JE. Bacillary angiomatosis. AIDS Clin Rev 1994:43-60.
167. 168. Isenbarger DW, Aronson NE. Lytic vertebral lesions: an unusual manifestations of AIDS-associated Kaposi's sarcoma. Clin Infect Dis 1994;19:751-5.
168. 169. Curry A, Turner AJ, Lucas S. Opportunistic protozoan infections in human immunodeficiency virus disease: Review highlighting diagnostic and therapeutic aspects. J Clin Pathol 1991;44:182-93.
169. 170. Raviglione MC. Extrapulmonary pneumocystosis: The first 50 cases. Rev Int Dis 1990;12:1127-38.
170. 171. Coulman CV, Green I, Archibald RW. Cutaneous pneumocystosis. Ann Int Med 1987;106:396-8.
171. 172. Schinella RA, Breda SD, Hammerschlag PE. Otic infection due to Pneumocystis carinii in an apparently healthy man with antibody to the human immunodeficiency virus. Ann Int Med 1987;106:339-400.
172. 173. Litwin MA, Williams CM. Cutaneous Pneumocystis carinii infection mimicking Kaposi's sarcoma. Ann Int MEd 1992;117:48-9.
173. 174. Hennessey NP, Parro EL, Cockerell CJ. Cutaneous Pneumocystis carinii infection in patients with acquired immunodeficiency syndrome. Arch Dermatol 1991;127:1699-701.
174. 175. Hennessey NP, Cockerell CJ. Cutaneous Pneumocystis carinii infection in patients with AIDS. Int Conf AIDS 1991; 7:241.
175. 176. Rosenthal D, LeBoit PE, Klumpp L, et al. Human immunodeficiency virus-associated eosinophili folliculitis. A unique dermatosis associated with advanced human immunodeficiency virus infection. Arch Dermatol 1991;127: 206-9.
176. 177. Otley CC, Avram MR, Johnson RA. Isotretinion treatment of human immunodeficiency virus-associated eosinophilic folliculitis. Results of an open pilot trial. Arch Dermatol 1995;131:1047-50.
177. 178. Berger TG, Heon V, King C, et al. Itraconazole therapy for human immunodeficiency virus-associated eosinophilic folliculitis. Arch Dermatol 1995;131:358-60.
178. 179. Smith KJ, Skelton HG, Yeager J, et al. Metronidazole for eosinophilic pustular folliculitis in human immunodeficiency virus type I-positive patient. Arch Dermatol 1995; 131:1089-91.
179. 180. Blauvelt A, Plott RT, Spooner K, et al. Eosinophilic folliculitis associated with the acquired immunodeficiency syndrome responds well to permethrin. Arch Dermatol 1995;131:360-1.
180. 181. Buchness MR, Lim HW, Hatcher VA, et al. Eosinophilic pustular folliculitis in the acquired immunodeficiency syndrome. Treatment with ultraviolet B phototherapy. N Engl J Med 1988;318:1183-6.
181. 182. Froschl M, Vogt HJ, Worret I. HIV infection as an endogenous stimulant of psoriasis. Int Conf AIDS 1993;9:488.
182. 183. Carminati G, Muratori S, Tarantini G. Psoriasis and HIV infection. Int Conf AIDS 1992;8:64.
183. 184. Froschl M, Stallmarin D, Landthaler M, et al. Psoriasis in HIV infections: clinical, histology, HLA tissue typing. Int Conf AIDS 1989;5:253.
184. 185. Obuch ML, Maurer TA, Becker B, et al. Psoriasis and human immunodeficiency virus infection. J Am Acad Dermatol 1991;24:970-2.
185. 186. Reveille JD, Conant MA, Duvic M. Human Immunodeficiency virus-associated psoriasis, psoriatic arthritis, and Reiter's syndrome: A disease continuum? Arthritis Rheum 1990;33:1574-8.
186. 187. Hammett RJ, Edwards R. Longstanding psoriasis: A remission in a patient with AIDS and a falling T-cell count. Annu Conf Australas Soc HIV Med 1994;6:279.
187. 188. Ansari SJ, Chaker MB, Cockerell CJ. Concomitant psoriasis, seborrheic dermatitis, and disseminated cutaneous histoplasmosis in an HIV infected patient; an example of clinical mimicry with potentially serious consequences. Int Conf AIDS 1992;8:124.
188. 189. Jaffe D, May LP, Sanchez M, et al. Staphyloccal sepsis in HIV antibody seropositive psoriasis patients. J Am Acad Dermatol 1991;24:970-2.
189. 190. Johnson RA, Dover JS. Cutaneous manifestations of human immunodeficiency virus disease. In Fitzpatrick TB, Eisen AZ, Wolff K, et al, editors. Dermatology in general medicine. New York: McGraw-Hill, 1993;215:2666.
190. 191. Gray JD, Bottomley W, Layton AM, et al. The use of calciprotriol in HIV-related psoriasis. Clin Exp Dermatol 1992;17:342-3.
191. 192. Kaplan MH, Sadick NS, Wieder J, et al. Antipsoriatic effects of zidovudine in human immunodeficiency virus-associated psoriasis. J Am Acad Dermatol 1989;20;76-82.
192. 193. Cusini M, Alessi E, Zerboni R. Treatment of HIV-associated psoriasis with etretinate. Preliminary results. Int Conf AIDS 1990;6:357.
193. 194. Lightfoote M, Beer JZ, Smudzka B, et al. Modulation of immune response and HIV antigen expression in UVB-treated psoriasis patients. Int Conf AIDS 1994;10:184.
194. 195. Ranki A, Puska P, Mattinen S, et al. Effect of PUVA on immunologic and virologic findings in HIV-infected patients. J Am Acad Dermatol 1991;24:404-10.
195. 196. Maurer TA, Zackheim HS, Tuffanelli L, Berger TG. The use of methotrexate for treatment of psoriasis in patients with HIV infection. J Am Acad Dermatol 1994;31:372-5.
196. 197. Allen BR. use of cyclosporin for psoriasis in an HIV-positive patient. Lancet 1992;339:686.
197. 198. Lobo DV, Chu P, Grekin RD, et al. Non-melanoma skin cancer and infection with human immunodeficiency virus. Arch Dermatol 1991;128:623-7.
198. 199. McGregor JM, Newell M, Ross J, et al. Cutaneous malignant melanoma and human immune virus. A report of three cases. Br J Dermatol 1992;126:516-9.
199. 200. Tindall B, Finlayson R, Mutimer K, et al. Malignant melanoma with human immunodeficiency virus infection in three homosexual men. J Am Acad Dermatol 1989;587-91.
200. 201. Rivers JK, Kopf AW, Postel AH. Malignant melanoma in a man seropositive for the human immunodeficiency virus. J Am Acad Dermatol 1989;20:1127-8.
201. 202. Duvic M, Lowe L, Rapini RP, et al. Eruptive dysplastic nevi associated with HIV infection. Arch Dermatol 1989; 125:397-401.